Moreno Miguel, Pow Poh Yih, Tabitha Tan Su Teng, Nirmal Sonali, Larsson Andreas, Radhakrishnan Krishna, Nirmal Jayabalan, Quah Soo Tng, Geifman Shochat Susana, Agrawal Rupesh, Venkatraman Subbu
a NTU-Northwestern Institute for Nanomedicine (NNIN), School of Material Science & Engineering (MSE) , Nanyang Technological University (NTU) , Singapore.
b School of Biological Sciences , Nanyang Technological University , Singapore.
Expert Opin Drug Deliv. 2017 Aug;14(8):913-925. doi: 10.1080/17425247.2017.1343297. Epub 2017 Jul 3.
This paper describes the synthesis of thiolated chitosan-based hydrogels with varying degrees of crosslinking that has been utilized to modulate release kinetics of two clinically relevant FDA-approved anti-VEGF protein drugs, ranibizumab and aflibercept. These hydrogels have been fabricated into disc shaped structures for potential use as patches on ocular surface.
Protein conformational changes and aggregation after loading and release was evaluated by circular dichroism (CD), steady-state tryptophan fluorescence spectroscopy, electrophoresis and size-exclusion chromatography (SEC). Finally, the capacity of both released proteins to bind to VEGF was tested by ELISA and surface plasmon resonance (SPR) technology.
The study demonstrates the versatility of thiolated chitosan-based hydrogels for delivering proteins. The effect of various parameters of the hydrogel on protein release kinetics and mechanism of protein release was studied using the Korsmeyer-Peppas release model. Furthermore, we have studied the stability of released proteins in detail while comparing it with non-entrapped proteins under physiological conditions to understand the effect of formulation conditions on protein stability.
The disc-shaped thiolated chitosan-based hydrogels provide a potentially useful platform to deliver ranibizumab and aflibercept for the treatments of ocular diseases such as wet AMD, DME and corneal neovascularization.
